Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.-Reference-Cited by-同舟云学术

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

Published:1993-09 Issue:26 Volume:268 Page:19650-19655
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Göke R,Fehmann H.C.,Linn T,Schmidt H,Krause M,Eng J,Göke B

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference31 articles.

1. The incretin concept today

2. Glucagon-like peptide-1(7–36) amide is a new incretin/enterogastrone candidate

3. Glucagon-like peptide-1(7–37)/(7–36)amide is a new incretin

4. Insulinotropic glucagonlike peptide-I(7–37)/(7–36)amide A new incretin hormone

Cited by 463 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Trp-Cage on the Function and Stability of GLP-1R Agonist Exenatide Derivatives;Journal of Medicinal Chemistry;2024-09-10

2. Editorial: The rise and rise of peptide therapeutics for obesity-diabetes;Peptides;2024-09

3. GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management;Nature Metabolism;2024-08-19

4. The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius;Frontiers in Pharmacology;2024-08-16

5. Mechanisms of action and therapeutic applications of GLP-1 and dual GIP/GLP-1 receptor agonists;Frontiers in Endocrinology;2024-07-24